Our scientists approach each formulation project with the commercial product in mind. We structure development programs for our clients that integrate process development and scale-up, thereby removing the need for costly reformulation at later stages. With a full range of formulation and analytical development capabilities, as well as pilot scale manufacturing, we can accelerate your molecule through development to market.

• Characterization of physical properties
• Chemical reactivity and forced degradation studies
• Excipient compatibility studies
• Formulation development for early safety studies
• Prototype formulations for clinical trials
• Preliminary process identification 
• Commercial formulation development
• Process development optimization

Patheon recognizes the importance of moving your molecule to First Time in Human (FTIH) clinical studies fast while conserving your valuable Active Pharmaceutical Ingredients (API) in early development. Click here to learn more about our Quick to Clinic™ early phase development programs.